What is the latest price of imported dasatinib in 2025?

Dasatinib (Dasatinib) is a second-generation tyrosine kinase inhibitor that has been officially launched in mainland China and has been included in the national medical insurance drug catalog. It has become an important targeted drug for the treatment of patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). As an original drug, dasatinib's efficacy has been verified by multiple international clinical studies. It is considered to have unique advantages in combating some imatinib-resistant mutations, especially it has good inhibitory activity against most BCR-ABL mutation types except T315I.

In terms of price, the common specifications of dasatinib sold in mainland China include50 mg 60 tablets and 20 mg 60 tablets. The original price of each box before medical insurance is about RMB 10,000. Since it is included in the national medical insurance directory, eligible patients can enjoy part or most of the cost reimbursement after a prescription is issued by a specialist, greatly reducing their financial burden. However, for patients who are not covered by medical insurance or do not qualify for reimbursement, the cost of purchasing drugs is still high.

In comparison, the overseas price of dasatinib’s original drug is significantly higher. Taking the United States as an example, the price of medicines of the same dosage often exceeds US$10,000 per box, which is a heavy cost burden without insurance reimbursement. In addition, there are also some imitation versions on the market, mainly produced by pharmaceutical factories in India, Bangladesh and other countries, such as Bangladesh Beacon Pharmaceutical, Yaopin International and other brands. These generic drugs are basically the same as the original drugs in terms of ingredients, dosage and usage, but the price is significantly lower, usually between a few hundred to one thousand yuan. However, it should be noted that generic drugs have not been officially registered and marketed in mainland China, and their purchase often needs to be completed through overseas channels. At the same time, they must have a doctor's prescription to comply with regulations and patient drug safety requirements.

Reference materials:https://go.drugbank.com/drugs/DB01254